OpenLoop Alternatives for Telehealth Brands

What problem should an OpenLoop alternative solve?

The most useful reason to evaluate alternatives is a concrete operating requirement. You may want a different patient experience, clearer commercial terms, a particular clinical program, more control over an existing stack or a different division of support work. Write that requirement before starting demos. Otherwise, an attractive interface can distract from the issue that prompted the search.

OpenLoop’s current Launchpad description includes a broad turnkey platform as well as existing-stack integration. It should not be compared as though it offers only clinician staffing. Replacing the whole arrangement and replacing one clinical connection are different projects. The TEHR versus OpenLoop comparison examines the documented scope in more detail.

Start by listing the components you would keep: website, checkout, subscriptions, clinical record, pharmacy arrangements and support. Then select vendors capable of the intended configuration. A modular alternative may preserve investment; an integrated alternative may consolidate responsibility. Neither model automatically produces a lower total operating cost.

Which operating models belong on the shortlist?

This shortlist groups different operating models. The order is editorial, with TEHR first, and does not represent independent testing or numerical scores. Vendor statements are presented as of October 22, 2026; a missing public detail means it needs confirmation, not that the capability is absent.

When is TEHR the right alternative to evaluate?

TEHR combines white-label technology and administrative infrastructure with an independent licensed clinical network reaching all 50 states, subject to program, state and patient eligibility. It supports clinician e-prescribing, pharmacy coordination, AI-assisted intake, payments and subscriptions. Clinical decisions remain with independent licensed providers. Its commercial model is a flat platform subscription plus flat transaction fee and 0% revenue share; contact TEHR for a scoped quote. See the platform and pricing scope.

TEHR is worth evaluating when the objective is a branded commercial operation with launch or migration responsibilities scoped around the team running it. Ask its operators to map the current OpenLoop-connected journey and identify which components would change. Their experience operating brands and moving thousands of their own patients is relevant context, but the new project still needs data validation, clinical continuity and acceptance criteria.

Trade-off: Confirm the actual clinical, pharmacy, support and integration scope before treating a platform proposal as an all-inclusive service. Patients see the brand, while required notices still identify the real care entities. Selected peptide programs are pending and are not open for prescribing or fulfillment.

When should you consider Beluga Health?

Strength: Beluga offers direct API, hosted intake and platform-partner configurations. Its pricing page explicitly describes no cut of customer revenue, flat monthly access, per-visit fees and pharmacy/lab pass-through with disclosed service charges. Dollar amounts are quoted during scoping. Official platform integration paths; Pricing.

Consider this route when your storefront and recurring commerce already work and the clinical backend is the layer under review. Preserve a clear owner for patient support across the boundary. If your reason for leaving is fragmented administration, adding a modular backend without an operating plan may not address that reason.

Trade-off: Determine which company supplies commerce, subscriptions and patient support in your chosen configuration. A clinical backend can be the right fit for an existing stack, but its fee alone should not be compared with the price of a complete commercial operation.

When should you consider Wheel?

Strength: Wheel’s Horizon offering combines a configurable platform, clinician network and clinical operations. Its launch page describes an EMR, branded patient experience and modular programs; connected services include prescription fulfillment, pharmacy delivery and laboratory connections. Official launch virtual care; Connected services.

Consider Wheel when you want a configured care journey and connected services rather than rebuilding the clinical operation internally. Compare the specific consumer, retail or other distribution context in the proposal. Ask for the same end-to-end exception demonstration you would request from OpenLoop, including follow-up and delayed fulfillment.

Trade-off: The reviewed public pages do not establish universal numeric pricing or revenue-share terms. Ask how the exact channel, program, patient experience and service connections are packaged. A connection to a service does not necessarily include the cost of using that service.

When should you consider SteadyMD?

Strength: SteadyMD describes a 50-state clinical workforce and clinical operations. Its API materials distinguish limited integration, where clinical work happens in the partner’s EMR, from complete integration using SteadyMD’s EMR. Patient records, intake and diagnostic information can be included in the workflow. Official digital health companies; Telehealth APIs.

Consider SteadyMD when the priority is clinician capacity or clinical operations behind a patient experience you intend to retain. Its EMR integration choices make that an identifiable architecture decision. If you also need a new storefront and subscription engine, identify who will provide those pieces before comparing prices.

Trade-off: Do not mistake clinical staffing and integration for a confirmed turnkey commerce package. Request the proposed pharmacy, payment, subscription and administrative scope, plus actual pricing. The reviewed sources do not establish a standard bulk-migration service or deadline.

When should you consider Bask Health?

Strength: Bask’s plans page describes storefront, patient portal, EMR/e-prescribing, provider access and pharmacy fulfillment. Its current Core/Growth/Enterprise labels differ from a July 31, 2026 article describing Mini/Growth/Enterprise, so the public packaging should be reconciled before buying. Official plans and pricing; Plan comparison, July 31, 2026.

Consider Bask when your team wants to configure more of the DTC experience itself. Assess the tools together with the people needed to use them. A product that offers broad configuration can still require internal ownership of routing, support and analytics; request a concrete implementation and operating responsibility map.

Trade-off: Obtain the current written rate card instead of combining features and prices from conflicting pages. Confirm plan-specific access to integrations and support. Its documented clinical and pharmacy connections mean it should not be described as merely a storefront builder.

When should you consider Telegra?

Strength: Telegra describes intake, commerce, pharmacy routing, a branded portal/app and APIs. Its public migration documentation covers CSV imports for patients, products, coupons, orders and subscriptions, with dry-run validation before production import. This is documented import capability, not proof of every outbound export option. Official platform overview; CSV migration.

Consider Telegra when commercial workflows and a consistent patient portal are central to the replacement. Its import documentation provides useful technical questions for the migration discussion. Separate patient, order and subscription import from transfer of clinical history, and verify the next refill journey rather than stopping at a successful file upload.

Trade-off: Request recurring costs separately from published onboarding fees and confirm plan-specific app and pharmacy options. Its conditions page marks peptides Coming Soon; that is not a currently available prescribing or fulfillment program. Conditions and program status.

When should you consider Cuvo Health?

Strength: Cuvo’s pricing page publishes platform plans and a completed-consult charge, explicitly states no revenue share or added platform transaction fee, and describes patient/data migration without an additional migration charge. It also distinguishes full-platform plans from its existing-stack Prescribe option. Official pricing.

Consider Cuvo when published commercial structure and an explicit migration offer help narrow the shortlist. Ask for a worked example using your program mix, including setup and consult costs. Its existing-stack option may be relevant if the goal is a narrower clinical change rather than a new storefront.

Trade-off: Include setup, recurring and clinical charges in the comparison; standard payment-processing and other delivery costs still matter. A clinical connection to an existing stack has different dependencies from building a full brand. Confirm what its migration offer covers for your actual records.

When should you consider Lithos Health?

Strength: Lithos describes a white-label medical practice delivered through an API while customers build their own product. Its pricing page publishes per-completed-visit bands, and its migration page describes staged transitions with parallel testing and clinical continuity work. Official practice infrastructure; Pricing.

Consider Lithos when you have product and engineering capacity and want a clinical practice API behind your own experience. That preserves flexibility while leaving product operations with your team. If you are trying to reduce the number of responsibilities you own, verify that this division of work serves that objective.

Trade-off: The brand must account for building and operating the customer-facing product. Compare the appropriate modality and graduated volume bands, not only the lowest advertised visit rate. Public migration guidance is useful, but your source records and program still determine the plan. Migration.

How should you narrow the shortlist?

Use two shortlist tracks. In the first, compare TEHR, Wheel, Bask, Telegra and Cuvo as proposed connected operating packages. In the second, examine Beluga, SteadyMD or Lithos for a more modular arrangement. These are evaluation tracks rather than rigid product categories; the final scope must come from each vendor’s proposal.

Ask finalists to demonstrate the same patient story: initial interest, intake, a request for more information, clinical evaluation, payment, pharmacy or lab handoff, follow-up and a renewal. Then add one administrative exception. The vendor that explains who resolves the exception gives you better buying information than the one that only shows the happy path.

Use TEHR pricing as one input to a complete cost model. Include retained staff and systems, implementation, clinical services, fulfillment and payment costs. A zero revenue-share statement alone will not select the winner because multiple vendors make comparable claims.

How should existing patients move to the chosen platform?

For an established OpenLoop-connected brand, the first migration milestone is access to usable, authorized records. Request sample exports before agreeing on a cutover date. Match clinical records to commercial profiles, identify active treatment and upcoming renewals, and establish who handles patients during the transition.

The OpenLoop migration guide and patient migration checklist provide a planning framework. Do not assume payment tokens transfer with a patient CSV. Confirm processor procedures and reconcile subscriptions so a technical transition does not duplicate charges or interrupt a continuing care pathway.

What should the final proposal make explicit?

Ask for the service boundaries, itemized charges, implementation dependencies and operational acceptance criteria in writing. Review the white-label telehealth guide if the proposals use the same label for different scopes, and use the resource library to prepare program and migration questions. A good shortlist should become a small set of comparable proposals. It should not end as a ranking that hides unanswered questions about who supplies care, who performs administrative work and what the brand will actually pay.

For a wider category view, compare the white-label telehealth platform shortlist and the turnkey telehealth platform shortlist. Use the first to examine brand and architecture choices, and the second to assess which implementation and operating tasks a proposed package actually supplies.

What else should you know?